Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% below its 1-year average of 19.30%, near the low end of its 1-year range (0.00%–40.13%).
100.00% below its 12-month average of 19.30%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 40.13%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
19.30%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
37.56%
median of 671 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$553584.00
Gross Margin
20.00%
TTM Avg
28.69%
3Y Avg
28.89%
5Y Avg
35.93%
Market Cap
$834083.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
4.91%
5Y Avg
3.27%
Market Cap
$861788.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
16.67%
Market Cap
$873327.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$388862.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
2.16%
5Y Avg
0.42%
Market Cap
$1.03M
Gross Margin
-1.87%
TTM Avg
-0.94%
3Y Avg
-0.47%
5Y Avg
-0.37%
Market Cap
$1.07M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CDT Equity Inc. (CDT) | $670379.00 | 0.00% | 19.30% | 0.00% | N/A |
| HCW Biologics Inc. (HCWB)vs › | $553584.00 | 20.00% | 28.69% | 28.89% | 35.93% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $834083.00 | 0.00% | 0.00% | 4.91% | 3.27% |
| Decoy Therapeutics Inc. (DCOY)vs › | $861788.00 | 0.00% | 0.00% | 0.00% | 16.67% |
| Bone Biologics Corporation (BBLG)vs › | $873327.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| GlucoTrack, Inc. (GCTK)vs › | $877957.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Niki BioSolutions, Inc. (NIKI)vs › | $388862.00 | 0.00% | 0.00% | 2.16% | 0.42% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -1.87% | -0.94% | -0.47% | -0.37% |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | 10.32% | 11.11% | 16.34% | 16.34% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 40.13% |
| 2026-03-29 | 37.06% |
| 2025-12-31 | 0.00% |
| 2025-09-28 | 0.00% |
| 2025-06-29 | 0.00% |
| 2025-03-30 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-29 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
